Active Myeloid Target Compound Combinations in MDS/MPN Overlap Syndromes Overlap Syndromes (ABNL-MARRO)

NCT04061421 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

94

Enrollment

OTHER

Sponsor class

Conditions

MDS/MPN

Interventions

DRUG: ASTX727
DRUG: Itacitinib
DRUG: Ruxolitinib

Sponsor

Michael Savona

Collaborators

[object Object]
[object Object]
[object Object]